KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Goodwill & Intangibles: 2018-2024

Historic Goodwill & Intangibles for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Dec 2024 value amounting to $4.4 million.

  • Aurinia Pharmaceuticals' Goodwill & Intangibles fell 13.48% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 13.48%. This contributed to the annual value of $4.4 million for FY2024, which is 12.50% down from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Goodwill & Intangibles stood at $4.4 million for FY2024, which was down 12.50% from $5.0 million recorded in FY2023.
  • In the past 5 years, Aurinia Pharmaceuticals' Goodwill & Intangibles ranged from a high of $9.3 million in FY2020 and a low of $4.4 million during FY2024.
  • Its 3-year average for Goodwill & Intangibles is $5.3 million, with a median of $5.0 million in 2023.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Goodwill & Intangibles increased by 5.30% in 2020, and later declined by 23.55% in 2022.
  • Over the past 5 years, Aurinia Pharmaceuticals' Goodwill & Intangibles (Yearly) stood at $9.3 million in 2020, then dropped by 9.94% to $8.4 million in 2021, then decreased by 23.55% to $6.4 million in 2022, then decreased by 22.54% to $5.0 million in 2023, then dropped by 12.50% to $4.4 million in 2024.